InsidersTradesSigma
Explore the full record of transactions filed by Vellanki Avanish, Chief Executive Officer. Insider active across 1 companies, notably Rain Therapeutics Inc.. Cumulatively, 3 filings have been recorded. Total volume traded: €54k. The latest transaction was disclosed on 1 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations
Vellanki Avanish is the President and CEO of Rain Therapeutics Inc. He leads the company and is responsible for its overall strategy. His leadership is essential to achieve the company's objectives and for its future development.